These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21300937)

  • 1. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis.
    Foley DL; Morley KI
    Arch Gen Psychiatry; 2011 Jun; 68(6):609-16. PubMed ID: 21300937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis.
    Teasdale SB; Ward PB; Rosenbaum S; Watkins A; Curtis J; Kalucy M; Samaras K
    Br J Nutr; 2016 Jun; 115(11):1987-93. PubMed ID: 27153205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
    Pérez-Iglesias R; Martínez-García O; Pardo-Garcia G; Amado JA; Garcia-Unzueta MT; Tabares-Seisdedos R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):41-51. PubMed ID: 24103107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
    J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heart of the matter: cardiometabolic care in youth with psychosis.
    Curtis J; Newall HD; Samaras K
    Early Interv Psychiatry; 2012 Aug; 6(3):347-53. PubMed ID: 22221395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis.
    Correll CU; Højlund M; Graham C; Todtenkopf MS; McDonnell D; Simmons A
    Int J Neuropsychopharmacol; 2023 Jul; 26(7):451-464. PubMed ID: 37326421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.
    Bushe CJ; Bradley AJ; Doshi S; Karagianis J
    Int J Clin Pract; 2009 Dec; 63(12):1743-61. PubMed ID: 19840151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis.
    Galling B; Roldán A; Nielsen RE; Nielsen J; Gerhard T; Carbon M; Stubbs B; Vancampfort D; De Hert M; Olfson M; Kahl KG; Martin A; Guo JJ; Lane HY; Sung FC; Liao CH; Arango C; Correll CU
    JAMA Psychiatry; 2016 Mar; 73(3):247-59. PubMed ID: 26792761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
    Zhang JP; Lencz T; Zhang RX; Nitta M; Maayan L; John M; Robinson DG; Fleischhacker WW; Kahn RS; Ophoff RA; Kane JM; Malhotra AK; Correll CU
    Schizophr Bull; 2016 Nov; 42(6):1418-1437. PubMed ID: 27217270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
    Strassnig M; Miewald J; Keshavan M; Ganguli R
    Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.
    Cooper SJ; Reynolds GP; ; Barnes T; England E; Haddad PM; Heald A; Holt R; Lingford-Hughes A; Osborn D; McGowan O; Patel MX; Paton C; Reid P; Shiers D; Smith J
    J Psychopharmacol; 2016 Aug; 30(8):717-48. PubMed ID: 27147592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study.
    Gaughran F; Stahl D; Stringer D; Hopkins D; Atakan Z; Greenwood K; Patel A; Smith S; Gardner-Sood P; Lally J; Heslin M; Stubbs B; Bonaccorso S; Kolliakou A; Howes O; Taylor D; Forti MD; David AS; Murray RM; Ismail K;
    Br J Psychiatry; 2019 Dec; 215(6):712-719. PubMed ID: 31347480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental health starts with physical health: current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis.
    Gates J; Killackey E; Phillips L; Álvarez-Jiménez M
    Lancet Psychiatry; 2015 Aug; 2(8):726-742. PubMed ID: 26249304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.